SHW DCF Flags $218 Intrinsic Value vs $311 Price: Overvaluation Spotlight

What happened

A GuruFocus DCF analysis published on June 10, 2026 estimates Sherwin-Williams' intrinsic value at $218 per share, a sharp contrast to the current trading price around $311. This builds on DeepValue's WAIT rating, which already highlighted that at $325.7 the stock trades at 31.2x P/E and 21.6x EV/EBITDA, leaving no margin of safety. The DCF model implies the market is pricing in a volume recovery and margin expansion that may not materialize given tariff-driven raw inflation and muted housing demand. While the DCF assumptions are not detailed, the wide gap reinforces the thesis that execution must prove the earnings bridge. Investors should view this as a confirmation of overvaluation risk rather than a precise target, but it amplifies the need for evidence of EPS delivery before adding positions.

Implication

The $218 intrinsic value is a stark warning that current valuations embed aggressive assumptions. DeepValue's base case values SHW at $335, but even that requires flawless execution. Until quarterly results confirm gross margin expansion and EPS guidance is maintained, the risk-reward is unfavorable. A pullback to the $300 attractive entry zone or confirmation of the bull case (housing recovery, margin expansion) would be needed to reconsider. For existing holders, the DCF adds a reason to trim if the stock trades above $360 as DeepValue suggests.

Thesis delta

The DCF intrinsic value of $218 introduces a new lower bound for potential downside and reinforces overvaluation concerns. Previously, DeepValue's bear case was $290; now an independent DCF suggests even deeper discount. This shifts the thesis delta from 'wait for execution proof' to 'the burden of proof is higher—the market must deliver not just EPS but a re-rating lower to align with fundamentals.' The probability of immediate upside diminishes as the DCF highlights potential 30%+ downside if assumptions prove optimistic.